[HTML][HTML] B-1 cell heterogeneity and the regulation of natural and antigen-induced IgM production

N Baumgarth - Frontiers in immunology, 2016 - frontiersin.org
A small subset of B cells, termed B-1 cells, with developmental origins, phenotypes, and
functions that are distinct from those of conventional B cells exist in mice. It contributes the …

The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease

MB Fessler - Pharmacology & therapeutics, 2018 - Elsevier
Abstract The Liver X Receptors (LXRs) are oxysterol-activated transcription factors that
upregulate a suite of genes that together promote coordinated mobilization of excess …

[HTML][HTML] Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE-/-mice

C Ma, R Xia, S Yang, L Liu, J Zhang, K Feng… - Theranostics, 2020 - ncbi.nlm.nih.gov
Background and Purpose: Atherosclerosis is an underlying cause of coronary heart disease.
Foam cell, a hallmark of atherosclerosis, is prominently derived from monocyte-differentiated …

Transcription factor 21 accelerates vascular calcification in mice by activating the IL-6/STAT3 signaling pathway and the interplay between VSMCs and ECs

X Zhao, M Zhu, S Wang, T Zhang, X Wei… - Acta Pharmacologica …, 2023 - nature.com
Vascular calcification is caused by the deposition of calcium salts in the intimal or tunica
media layer of the aorta, which increases the risk of cardiovascular events and all-cause …

[HTML][HTML] ERK1/2 inhibition reduces vascular calcification by activating miR-126-3p-DKK1/LRP6 pathway

P Zeng, J Yang, L Liu, X Yang, Z Yao, C Ma, H Zhu… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: Vascular microcalcification increases the risk of rupture of vulnerable
atherosclerotic lesions. Inhibition of ERK1/2 reduces atherosclerosis in animal models while …

Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice

Y Chen, Y Duan, X Yang, L Sun, M Liu… - … , and vascular biology, 2015 - Am Heart Assoc
Objective—Activation of liver X receptor (LXR) inhibits atherosclerosis but induces
hypertriglyceridemia. In vitro, it has been shown that mitogen-activated protein kinase kinase …

Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes

H Hosseini, Y Li, P Kanellakis, C Tay… - Cardiovascular …, 2015 - academic.oup.com
Aims To investigate whether activation of atheroprotective peritoneal B1a cells by apoptotic
cells or phosphatidylserine liposomes (PSLs) can enhance their protective actions during …

[HTML][HTML] 25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism [S]

Y Liu, Z Wei, X Ma, X Yang, Y Chen, L Sun, C Ma… - Journal of lipid …, 2018 - ASBMB
Cholesterol 25-hydroxylase (CH25H) catalyzes the production of 25-hydroxycholesterol (25-
HC), an oxysterol that can play an important role in different biological processes. However …

[HTML][HTML] The role of cytokines in cholesterol accumulation in cells and atherosclerosis progression

AM Markin, YV Markina, AI Bogatyreva… - International Journal of …, 2023 - mdpi.com
Atherosclerosis is the most common cardiovascular disease and is the number one cause of
death worldwide. Today, atherosclerosis is a multifactorial chronic inflammatory disease with …

A novel therapy for hepatic cholestasis treatment—the combination of rosiglitazone and fenofibrate

Y Chen, S Yang, L Liu, X Yang, Y Duan… - European Journal of …, 2023 - Elsevier
Hepatic cholestasis can develop into liver fibrosis and eventually liver failure. Currently,
ursodeoxycholic acid (UDCA) or UDCA combined with fenofibrate is used for cholestasis …